Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for Pediatric Migraine
78 locations incl. Scottsdale
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04649242·Phase 3·Recruiting·Listed Dec 2020
ANESC Research
Clinical research site in El Paso, Texas · 1155 WESTMORELAND DR STE 215, EL PASO, TX 79925-5623 · (915) 201-0702 · Website
As of September 2026, 13 paid clinical trials are recruiting at ANESC Research in El Paso, Texas. Active studies at this site cover conditions such as Focal Epilepsy, Acute Treatment of Migraine and Agitation. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at ANESC Research? We'll email you when one opens.
Recruiting clinical trials at ANESC Research (13)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for Acute Treatment of Migraine
61 locations incl. Scottsdale
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04743141·Phase 3·Recruiting·Listed Feb 2021
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for Agitation
48 locations incl. Homewood
Sponsor: Celgene
Sex: All·Age: 55 - 90
Code: NCT06808984·Phase 2·Recruiting·Listed Feb 2025
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for Primary Generalized Tonic-Clonic Seizures
48 locations incl. Mobile
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 12+
Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
for Alzheimer Disease
49 locations incl. Gilbert
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 55 - 90
Code: NCT06585787·Phase 3·Recruiting·Listed Sep 2024
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
for Alzheimer Disease
32 locations incl. Scottsdale
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 55 - 90
Code: NCT07011732·Phase 3·Recruiting·Listed Jun 2025
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for Obesity
20 locations incl. Gilbert
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07571109·Phase 3·Recruiting·Listed May 2026
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for Obesity
17 locations incl. San Diego
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07571005·Phase 3·Recruiting·Listed May 2026
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for Multiple Sclerosis
22 locations incl. Cullman
Sponsor: Sanofi
Sex: All·Age: 18 - 60
Code: NCT07325292·Phase 3·Recruiting·Listed Jan 2026
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
for Focal Seizures
24 locations incl. Phoenix
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 12 - 75
Code: NCT07233239·Phase 1·Recruiting·Listed Nov 2025
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for Generalized Myasthenia Gravis
19 locations incl. Phoenix
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All·Age: 18+
Code: NCT06463587·Phase 3·Recruiting·Listed Jun 2024
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for Chronic Inflammatory Demyelinating Polyneuropathy
3 locations incl. Tampa
Sponsor: Kedrion S.p.A.
Sex: All·Age: 18+
Code: NCT06752356·Phase 3·Recruiting·Listed Dec 2024
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
for Multiple Sclerosis
6 locations incl. Farmington Hills
Sponsor: ModernaTX, Inc.
Sex: All·Age: 18 - 55
Code: NCT06735248·Phase 2·Recruiting·Listed Dec 2024
Get new-trial alerts for ANESC Research
We'll email you whenever a new clinical trial starts recruiting at this research site in El Paso, TX. Unsubscribe anytime.
More research sites in El Paso
- El Paso Children's Hospital (22 trials)
- Texas Oncology - West Texas (5 trials)
- Renovatio Clinical - El Paso (5 trials)
- Texas Arthritis Center (4 trials)
- Western Sky Medical Research (4 trials)
- University of Texas at El Paso (3 trials)
- David Turbay, MD (3 trials)
- GSK Investigational Site (3 trials)
- Proactive El Paso,LLC (3 trials)
- University Medical Center of El Paso (3 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.